EWF
ABBV icon

Epstein & White Financial’s AbbVie ABBV Stock Holding History

Epstein & White Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,445
Closed -$256K – 71
2019
Q2 		$256K Buy
3,445
+486
+16% +$38.2K 0.14% 65
2019
Q1 		$241K Sell
2,959
-376
-11% -$30.8K 0.14% 66
2018
Q4 		$309K Buy
3,335
+817
+32% +$71.8K 0.19% 48
2018
Q3 		$237K Sell
2,518
-345
-12% -$32.7K 0.16% 76
2018
Q2 		$293K Sell
2,863
-294
-9% -$28.7K 0.22% 75
2018
Q1 		$328K Sell
3,157
-2,650
-46% -$291K 0.21% 75
2017
Q4 		$614K Buy
+5,807
New +$547K 0.36% 43

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Epstein & White Financial's ABBV Position: Q3 2019 in Review

Epstein & White Financial sold out of AbbVie (ABBV) in Q3 2019, closing a stake of 3,445 shares — an estimated $256K sold.

Epstein & White Financial first reported a position in ABBV in Q4 2017 and held it in 7 quarters. The position peaked at $614K in Q4 2017. 2,002 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

  • Epstein & White Financial reported no remaining AbbVie position as of Q3 2019 after selling out during the quarter.
  • Epstein & White Financial sold 3,445 AbbVie shares in Q3 2019, an estimated $256K.
  • Epstein & White Financial first reported a position in AbbVie in Q4 2017 and held it in 7 quarters.
  • Epstein & White Financial's AbbVie position peaked at $614K in Q4 2017.
  • 2,002 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on Epstein & White Financial's 13F filing for Q3 2019, filed 15 Oct 2019.